参考文献
1: Anekonda TS, Quinn JF. Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine. Biochim Biophys Acta. 2011 Dec;1812(12):1584-90. doi: 10.1016/j.bbadis.2011.08.013. Epub 2011 Sep 8. Review. PubMed PMID: 21925266; PubMed Central PMCID: PMC3275089.
2: Hansson L. How to study the role of hypertension in atherosclerosis. Lessons from MIDAS. Multicentre Isradipine Diuretic Atherosclerosis Study. Blood Press Suppl. 1996;4:16-9. Review. PubMed PMID: 8973777.
3: Panuccio D, Trabatti MR, Bernardini A, Capone A. [Metabolic tolerance of isradipine. Evaluation after three months of therapy]. Clin Ter. 1995 Nov;146(11):729-36. Review. Italian. PubMed PMID: 8720349.
4: Blecker D. Antihypertensive therapy with isradipine in patients with special safety concerns. Angiology. 1994 Dec;45(12):997-1008. Review. PubMed PMID: 7985835.
5: Frishman WH. Calcium-channel entry blocker therapy for hypertensive patients with concomitant renal impairment: a focus on isradipine. J Clin Pharmacol. 1994 Dec;34(12):1164-72. Review. PubMed PMID: 7738211.
6: Walton T, Symes LR. Felodipine and isradipine: new calcium-channel-blocking agents for the treatment of hypertension. Clin Pharm. 1993 Apr;12(4):261-75. Review. PubMed PMID: 8458178.
7: Feneck RO, Underwood SM, Walesby RK. Isradipine and the coronary circulation. Acta Anaesthesiol Scand Suppl. 1993;99:38-42. Review. PubMed PMID: 8480505.
8: Hansson L. Isradipine: a profile in essential hypertension. Acta Anaesthesiol Scand Suppl. 1993;99:26-8. Review. PubMed PMID: 8480503.
9: Marty J. Role of isradipine and other antihypertensive agents in the treatment of peri- and postoperative hypertension. Acta Anaesthesiol Scand Suppl. 1993;99:53-5. Review. PubMed PMID: 8097608.
10: Man in't Veld AJ. The place of isradipine in the treatment of hypertension. Am J Hypertens. 1991 Feb;4(2 Pt 2):96S-102S. Review. PubMed PMID: 1827026.
11: Miller H. Isradipine: overall clinical experience in hypertension in the United States. Am J Hypertens. 1991 Feb;4(2 Pt 2):135S-139S. Review. PubMed PMID: 1827004.
12: Vidt DG. Isradipine in the treatment of hypertension: a clinical profile. Cleve Clin J Med. 1990 Nov-Dec;57(8):677-84. Review. PubMed PMID: 2147874.
13: Fitton A, Benfield P. Isradipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs. 1990 Jul;40(1):31-74. Review. PubMed PMID: 2143980.
14: Sauter A, Rudin M. Experimental studies with isradipine in stroke. Drugs. 1990;40 Suppl 2:44-51. Review. PubMed PMID: 2150641.
15: Rüegg UT, Hof RP. Pharmacology of the calcium antagonist isradipine. Drugs. 1990;40 Suppl 2:3-9. Review. PubMed PMID: 2150637.
16: Hansson L. Isradipine in hypertension. Drugs. 1990;40 Suppl 2:10-4. Review. PubMed PMID: 2150633.
17: Dahlöf B. Cardiovascular effects of isradipine (Lomir) with special emphasis on haemodynamics and antihypertensive efficacy. A review. Cor Vasa. 1990;32(2 Suppl 1):23-34. Review. PubMed PMID: 2143458.
18: Brogden RN, Sorkin EM. Isradipine. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of mild to moderate hypertension. Drugs. 1995 Apr;49(4):618-49. Review. PubMed PMID: 7789292.
19: Bernini F, Soma MR, Corsini A, Paoletti R. Experimental and clinical effects of isradipine relevant to atherosclerosis. Am J Hypertens. 1994 Jul;7(7 Pt 2):30S-34S. Review. PubMed PMID: 7946176.
20: Hirschberger R. [Pharmacokinetics and -dynamics of retard formation of isradipine. Summary of studies]. Fortschr Med. 1993 Oct 30;111(30):481-4. Review. German. PubMed PMID: 8258429.
